Flores, Bb Girl .
HRN: 27-07-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2025
AMPICILLIN 250MG (VIAL)
05/08/2025
05/15/2025
IVTT
165mg
Q12 Hours
T/C Neonatal Pneumonia, PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes